Avances en DiabetologíaPub Date : 2014-09-01Epub Date: 2014-10-02DOI: 10.1016/j.avdiab.2014.07.001
Margarida Jansà, Mercedes Galindo, Maite Valverde, Carmen Yoldi, Mercè Vidal, Pilar Isla, en nombre de la Junta Directiva de la SED y su grupo de Educación Terapéutica (GEET)
{"title":"Posicionamiento de la Sociedad Española de Diabetes (SED) sobre el perfil curricular y profesional de los profesionales de enfermería expertos en la atención de las personas con diabetes, sus familiares o cuidadores","authors":"Margarida Jansà, Mercedes Galindo, Maite Valverde, Carmen Yoldi, Mercè Vidal, Pilar Isla, en nombre de la Junta Directiva de la SED y su grupo de Educación Terapéutica (GEET)","doi":"10.1016/j.avdiab.2014.07.001","DOIUrl":"10.1016/j.avdiab.2014.07.001","url":null,"abstract":"<div><p>Diabetes mellitus (DM) is one of the most prevalent chronic diseases worldwide. The prevalence of type<!--> <!-->2 diabetes in Spain is 13.8% (6% undiagnosed), while the incidence of type<!--> <!-->1 diabetes is 12-14 cases per100,000 inhabitants/year. DM consumes 8.2% of total health expenditure in Spain.</p><p>DM is a paradigmatic example of chronic disease that affects all ages, and requires continuous medical care to: (i)<!--> <!-->optimize metabolic control; (ii)<!--> <!-->prevent and treat acute complications and associated chronic complications; (iii)<!--> <!-->control cardiovascular risk factors (CVRF); and (iv)<!--> <!-->provide therapeutic education related to self-management for patients, relatives and caregivers. For quality of care, scientific societies advocate quality standards of therapeutic patient education programs, as well as interdisciplinary team work in which the diabetes expert/specialist nurse has an important role, especially that of educator.</p><p>Both the curricular and professional profiles of diabetes expert/specialist nurses in different countries are described. The Spanish Diabetes Society (SED) supports the academic profile of diabetes expert/specialist nurses via Master or post-graduate degrees and the need for continuing education. The competence profile is based on 5 domains: (I) Pathophysiology and Epidemiology of Diabetes Clinical Guidelines. (II) Culturally competent care throughout life. (III) Teaching and learning skills. (IV) Education for self-management. (V) Planning, management and research for effective self-management.</p></div>","PeriodicalId":100152,"journal":{"name":"Avances en Diabetología","volume":"30 5","pages":"Pages 150-155"},"PeriodicalIF":0.0,"publicationDate":"2014-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.avdiab.2014.07.001","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"91048912","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Avances en DiabetologíaPub Date : 2014-07-01Epub Date: 2014-07-30DOI: 10.1016/j.avdiab.2014.06.004
José Miguel González-Clemente
{"title":"Nuevos fármacos para la diabetes mellitus tipo 2: amigos o enemigos. Reflexiones sobre una nueva guía de «armonización» del tratamiento de la diabetes mellitus tipo 2","authors":"José Miguel González-Clemente","doi":"10.1016/j.avdiab.2014.06.004","DOIUrl":"10.1016/j.avdiab.2014.06.004","url":null,"abstract":"","PeriodicalId":100152,"journal":{"name":"Avances en Diabetología","volume":"30 4","pages":"Pages 91-94"},"PeriodicalIF":0.0,"publicationDate":"2014-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.avdiab.2014.06.004","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"88078084","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Avances en DiabetologíaPub Date : 2014-07-01Epub Date: 2014-07-30DOI: 10.1016/j.avdiab.2014.06.005
Miguel A. Rubio
{"title":"Cirugía bariátrica en el paciente con diabetes tipo 2 e índice de masa corporal < 35 kg/m2: siempre que sea posible","authors":"Miguel A. Rubio","doi":"10.1016/j.avdiab.2014.06.005","DOIUrl":"10.1016/j.avdiab.2014.06.005","url":null,"abstract":"","PeriodicalId":100152,"journal":{"name":"Avances en Diabetología","volume":"30 4","pages":"Pages 102-108"},"PeriodicalIF":0.0,"publicationDate":"2014-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.avdiab.2014.06.005","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"89015693","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Avances en DiabetologíaPub Date : 2014-07-01Epub Date: 2014-06-16DOI: 10.1016/j.avdiab.2014.04.002
Nuria Vilarrasa García
{"title":"Paciente con diabetes tipo 2 e índice de masa corporal 30-35 kg/m2. La cirugía siempre debe esperar","authors":"Nuria Vilarrasa García","doi":"10.1016/j.avdiab.2014.04.002","DOIUrl":"10.1016/j.avdiab.2014.04.002","url":null,"abstract":"","PeriodicalId":100152,"journal":{"name":"Avances en Diabetología","volume":"30 4","pages":"Pages 95-101"},"PeriodicalIF":0.0,"publicationDate":"2014-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.avdiab.2014.04.002","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"81403874","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Avances en DiabetologíaPub Date : 2014-07-01Epub Date: 2014-07-21DOI: 10.1016/j.avdiab.2014.04.003
Alberto Goday Arnó
{"title":"Epidemiología de la diabetes. La apasionante aventura de investigación de un diabetólogo","authors":"Alberto Goday Arnó","doi":"10.1016/j.avdiab.2014.04.003","DOIUrl":"10.1016/j.avdiab.2014.04.003","url":null,"abstract":"","PeriodicalId":100152,"journal":{"name":"Avances en Diabetología","volume":"30 4","pages":"Pages 109-114"},"PeriodicalIF":0.0,"publicationDate":"2014-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.avdiab.2014.04.003","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"90857173","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Avances en DiabetologíaPub Date : 2014-07-01Epub Date: 2014-07-16DOI: 10.1016/j.avdiab.2014.05.001
Magdalena Capponi, Carmen Quirós, Ignacio Conget, Enric Esmatjes, Marga Giménez
{"title":"Reclasificación y transferencia de insulina a sulfonilureas en un paciente con mutación en KCNJ11 tras 15 años de tratamiento con insulina","authors":"Magdalena Capponi, Carmen Quirós, Ignacio Conget, Enric Esmatjes, Marga Giménez","doi":"10.1016/j.avdiab.2014.05.001","DOIUrl":"10.1016/j.avdiab.2014.05.001","url":null,"abstract":"","PeriodicalId":100152,"journal":{"name":"Avances en Diabetología","volume":"30 4","pages":"Pages 115-117"},"PeriodicalIF":0.0,"publicationDate":"2014-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.avdiab.2014.05.001","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"75089794","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Avances en DiabetologíaPub Date : 2014-05-01Epub Date: 2014-06-02DOI: 10.1016/j.avdiab.2014.03.003
Cristina Hernández, Rafael Simó
{"title":"Neurodegeneration in diabetic retinopathy: Current concepts and therapeutic implications","authors":"Cristina Hernández, Rafael Simó","doi":"10.1016/j.avdiab.2014.03.003","DOIUrl":"10.1016/j.avdiab.2014.03.003","url":null,"abstract":"<div><p><span>Diabetic retinopathy (DR), the most common </span>complication of diabetes<span><span> and one of the leading causes of preventable blindness<span>, has been considered to be a microcirculatory disease of the retina. However, there is emerging evidence to suggest that retinal </span></span>neurodegeneration is an early event in the pathogenesis of DR, which participates in the development of microvascular abnormalities. Therefore, the study of the underlying mechanisms leading to neurodegeneration and the identification of the mediators linking neurodegeneration and microangiopathy will be essential for the development of new therapeutic strategies in the early stages of DR. In this review the mechanisms involved in neurodegeneration, as well as the link between neurodegeneration and microangiopathy have been updated. Finally, the therapeutic implications and new perspectives based on identifying those patients with retinal neurodegeneration are presented.</span></p></div>","PeriodicalId":100152,"journal":{"name":"Avances en Diabetología","volume":"30 3","pages":"Pages 72-79"},"PeriodicalIF":0.0,"publicationDate":"2014-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.avdiab.2014.03.003","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"83736872","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Avances en DiabetologíaPub Date : 2014-05-01Epub Date: 2014-05-24DOI: 10.1016/j.avdiab.2014.03.004
Ignacio Conget, Josep Vidal
{"title":"¿Por qué llamarle metabólica cuando en realidad lo que queremos decir es cirugía bariátrica en el paciente con diabetes tipo 2?","authors":"Ignacio Conget, Josep Vidal","doi":"10.1016/j.avdiab.2014.03.004","DOIUrl":"10.1016/j.avdiab.2014.03.004","url":null,"abstract":"","PeriodicalId":100152,"journal":{"name":"Avances en Diabetología","volume":"30 3","pages":"Pages 61-62"},"PeriodicalIF":0.0,"publicationDate":"2014-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.avdiab.2014.03.004","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"76227270","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Avances en DiabetologíaPub Date : 2014-05-01Epub Date: 2014-05-10DOI: 10.1016/j.avdiab.2014.03.001
Manuel Delgado Gómez
{"title":"¿Qué podemos esperar del control de la variabilidad glucémica?","authors":"Manuel Delgado Gómez","doi":"10.1016/j.avdiab.2014.03.001","DOIUrl":"10.1016/j.avdiab.2014.03.001","url":null,"abstract":"<div><p>Some aspects of glycemic variability are still not clear. Questions like the role that «short term glycemic variability» could play in the development of diabetic complications is still unanswered. On the other hand, A1C variability, or «long term glycemic variability», emerges as one of the most relevant actors in development and progression of the chronic vascular complications of diabetes. Furthermore, glycemic variability plays a central role in causing dangerous and unnoticed hypoglycemia, and it becomes the limiting factor to achieve an optimal regulation of diabetes. In this review, the most important aspects of glycemic variability are discussed, as well as clarifying, as far as is possible, what we should expect from its control. Some recommendations are also offered on how to evaluate it properly.</p></div>","PeriodicalId":100152,"journal":{"name":"Avances en Diabetología","volume":"30 3","pages":"Pages 63-71"},"PeriodicalIF":0.0,"publicationDate":"2014-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.avdiab.2014.03.001","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"80404593","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}